SSAO inhibitor (Trifermed)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSSAO inhibitor (Trifermed)
Drug Alias Namesemicarbazide-sensitive amine oxidase inhibitor (Trifermed)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmine oxidase, copper containing inhibitors
TargetsAmine oxidase, copper containing
Therapy Area/IndicationsDiabetic Angiopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrifermed SL
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrifermed SL
Active IndicationsN/A
Inactive IndicationsDiabetic Angiopathies

Other Information

ATC CodeN/A
Related LinksN/A